The Superpowers for Good Live Pitch event on March 17 will feature four companies presenting distinct approaches to health and sustainability in a televised format designed to include audience participation. My Diabetes Health, rHEALTH, GigaWatt, and BRG Therapeutics will pitch live, with viewers able to submit questions for founders and vote for the SuperCrowd Award winner during the broadcast.
Following the broadcast, a private investor session via Zoom will be open to anyone interested in investing in the companies, with free registration available at https://thesupercrowd.com/26q1pitch. The event is produced by The Super Crowd, Inc., a public benefit corporation focused on expanding impact crowdfunding by connecting investors with high-impact opportunities and helping entrepreneurs access capital.
Léa Bouhelier-Gautreau, a Senior Investment Associate in Impact Investing at KingsCrowd, noted that these companies demonstrate the breadth of the impact category, spanning preventive health, diagnostics, energy infrastructure, and early-stage therapeutics. The live format allows the public to see and question these differences directly, moving beyond polished presentations to testable pitches.
Sherwood Neiss of Crowdfund Capital Advisors emphasized that the format intentionally goes beyond traditional pitches by allowing viewer questions, creating a more authentic investment decision-making environment. Paul Lovejoy of Stakeholder Enterprise added that audience participation elevates the conversation by surfacing core questions about traction, validation, economics, and execution in real time for all viewers.
My Diabetes Health focuses on insurance-covered telehealth diabetes education, having served 8,600 patients with an average 1.6-point A1C improvement. The company's pitch will center on how education can function as a scalable intervention for diabetes management, with Bouhelier-Gautreau noting investors will want to understand the mechanics of scaling without losing effectiveness.
rHEALTH is developing a space-validated blood diagnostics platform for consumer and point-of-care use, with work connected to NASA and NIH. Neiss stated investors will want specifics about what's validated today, regulatory plans, and first customers, while Lovejoy emphasized the need to translate technical sophistication into simple, investable clarity about real-world applications.
GigaWatt, an established energy business operating for 19 years with over $54 million in revenue since 2019, aims to scale distributed energy solutions. The company's pitch will connect its operating track record to market tailwinds in electrification, with Bouhelier-Gautreau noting investors will want to understand where defensibility sits as the company pursues larger footprint.
BRG Therapeutics develops novel anticancer and antiviral therapeutics, with Lovejoy emphasizing that early-stage therapeutics requires a different evaluation approach than consumer-facing ventures. Bouhelier-Gautreau added that credible biotech pitches clearly articulate what's known, hypothesized, and remains to be proven, enabling informed investment decisions.
The March 17 broadcast will air live on Roku and Amazon Fire TV via the e360tv Network, with additional distribution through social channels. The event represents a growing trend toward democratizing investment opportunities while maintaining rigorous due diligence through public questioning and expert evaluation.
